扫描下面的二维码:
"乙肝"标签列表
Effect of Infliximab on the Efficacy of Peginterferon alfa-2b(PEG-2b) Plus Ribavirin(RBV) (3)2007-11-14
Effect of Infliximab on the Efficacy of Peginterferon alfa-2b(PEG-2b) Plus Ribavirin(RBV) (1)2007-11-14
Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(4)2007-11-13
Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(5)2007-11-13
Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(2)2007-11-13
Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(3)2007-11-13
Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(1)2007-11-13
HBV Core Curriculum:Current Treatment Options for Hepatitis B2007-11-08
在用聚乙二醇化干扰素 alfa-2b治疗的 HBeAg-阳性患者中 HBV 基因型可作为HBsAg 转阴预测因子2007-11-08
临床HBV治疗更新2007-11-08
DIRECT试验(每日剂量一致的干扰素和利巴韦林:联合治疗的疗效):既往聚乙二醇干扰素加利巴韦林治疗无应答的治疗:持续病毒学应答数据2007-11-07
慢性乙型肝炎一线治疗选择2007-11-07
乙型肝炎病毒耐药:临床医生为临床观众的概述 2007-11-07
慢性乙型肝炎治疗路线图解读2007-11-06
干扰素受体基质-1和HBx基因双重过表达引起的肝脏恶化前改变2007-11-06
替诺福韦对核苷类药物应用的HBV单纯感染患者疗效的多中心初步评估2007-11-06
辩论:拉米夫定耐药HBeAg-阴性患者最优管理策略是什么?2007-11-05
辩论:最好的拯救管理初始治疗无应答患者的策略是什么:换药或加药?2007-11-05
慢性乙型肝炎治疗新策略-最新乙型肝炎防治指南解读 任红2007-08-08
核苷(酸)类似物耐药与对策 成军2007-08-08